Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Rick

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Oncology Research and Treatment|November 29, 2017
Rehabilitation of Cancer Survivors with Long-Term ToxicitiesJan Schmielau, Oliver Rick, Monika Reuss-Borst, et al.
Deutsches Arzteblatt International|December 25, 2012
Reintegrating cancer patients into the workplaceOliver Rick, Eva-Maria Kalusche, Timm Dauelsberg, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 18, 2022
[Long-term survival in cancer: definitions, concepts, and design principles of survivorship programs]Corinna Bergelt, Carsten Bokemeyer, Inken Hilgendorf, et al.
Der Urologe. Ausg. A|June 2, 2016
[Rehabilitation of prostate cancer patients : A multidisciplinary consensus]Oliver Rick, J Böckmann, T Dauelsberg, et al.
Anti-Cancer Drugs|February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumorsKarin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
The Journal of Urology|February 16, 2005
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 casesKlaus-Peter Dieckmann, Peter Albers, Johannes Classen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Die Rehabilitation|June 25, 2024
[Return to Work after Cancer - a Systematic Review of Predictors in Germany]Clara Breidenbach, Nicole Ernstmann, Sophie Schellack, et al.
Annals of Surgery|July 26, 2005
Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumorsJörg Thomas Hartmann, Oliver Rick, Karin Oechsle, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Urology|May 21, 2010
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumorsAnja Lorch, Oliver Rick, Thomas Wündisch, et al.
Oncology Research and Treatment|November 29, 2017
Rehabilitation of Cancer Survivors with Long-Term ToxicitiesJan Schmielau, Oliver Rick, Monika Reuss-Borst, et al.
Deutsches Arzteblatt International|December 25, 2012
Reintegrating cancer patients into the workplaceOliver Rick, Eva-Maria Kalusche, Timm Dauelsberg, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 18, 2022
[Long-term survival in cancer: definitions, concepts, and design principles of survivorship programs]Corinna Bergelt, Carsten Bokemeyer, Inken Hilgendorf, et al.
Der Urologe. Ausg. A|June 2, 2016
[Rehabilitation of prostate cancer patients : A multidisciplinary consensus]Oliver Rick, J Böckmann, T Dauelsberg, et al.
Anti-Cancer Drugs|February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumorsKarin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
The Journal of Urology|February 16, 2005
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 casesKlaus-Peter Dieckmann, Peter Albers, Johannes Classen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Die Rehabilitation|June 25, 2024
[Return to Work after Cancer - a Systematic Review of Predictors in Germany]Clara Breidenbach, Nicole Ernstmann, Sophie Schellack, et al.
Annals of Surgery|July 26, 2005
Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumorsJörg Thomas Hartmann, Oliver Rick, Karin Oechsle, et al.
Pageof 4